Safety Study of Olopatadine Nasal Spray

Completed · Phase 3 · Has a placebo group

Conditions studied: Perennial Allergic Rhinitis

In brief

The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis.

Key facts

Study ID

NCT00578331

Run by

Alcon Research

People needed

890

Starts

2006-12-01

Expected to finish

2008-01-01

Last updated by the study team

2017-10-31

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with confirmed diagnosis of perennial allergic rhinitis who are 12 years and older

You may not qualify if…

• Age 11 years and younger

Where it is running

• Waco — Waco, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.